Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
novartis
zolgensma
5
×
clinical trials
gene therapy
national
national blog main
national top stories
avexis
boston blog main
fda
new york top stories
san francisco top stories
amgen
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
centers for disease control and prevention
detroit blog main
detroit top stories
drug pricing
drugs
genentech
glaxosmithkline
indiana blog main
indiana top stories
martin shkreli
new york blog main
pfizer
raleigh-durham blog main
raleigh-durham top stories
rna drugs
roche
san diego blog main
san diego top stories
san francisco blog main
What
biotech
drug
fda
news
roundup
therapy
topped
access
according
advanced
akcea
approved
atrophy
august
bio
busy
capacity
car
cases
cell
centers
cigarettes
consolidation
control
crispr
daily
days
deaths
decisions
devices
disease
driving
drugs
electronic
evrysdi
falcon
focus
friday
gene
good
Language
unset
5
×
Current search:
zolgensma
×
unset
×
@xconomy.com
4 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More